Envoy Medical (COCH) Depreciation & Amortization (CF) (2022 - 2026)
Envoy Medical (COCH) reported Depreciation & Amortization (CF) of $73000.0 for Q1 2026, up 19.67% on a YoY basis from $61000.0 in Q1 2025, and down 8.75% sequentially from $80000.0 in Q4 2025.
Envoy Medical (COCH) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends
Envoy Medical (COCH) has 5 years of Depreciation & Amortization (CF) data on file, last reported at $73000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 19.67% year-over-year to $73000.0; the trailing twelve-month figure through Mar 2026 stood at $329000.0 (up 27.52% YoY), and the FY2025 full-year result was $302000.0, up 74.57% from the prior year.
- Depreciation & Amortization (CF) declined to $73000.0 in Q1 2026, from $80000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $100000.0 in Q2 2024 to a low of $26000.0 in Q4 2022.
- A 5-year average of $55714.3 and a median of $48500.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Peak annual rise in Depreciation & Amortization (CF) reached 244.83% in 2024, while the deepest fall reached 0.0% in 2024.
- Tracing COCH's Depreciation & Amortization (CF) over 5 years: stood at $26000.0 in 2022, then soared by 84.62% to $48000.0 in 2023, then changed by 0.0% to $48000.0 in 2024, then soared by 66.67% to $80000.0 in 2025, then decreased by 8.75% to $73000.0 in 2026.
- Business Quant data shows COCH's Depreciation & Amortization (CF) at $73000.0 in Q1 2026, $80000.0 in Q4 2025, and $76000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Envoy Medical | 45.50 Mn | 20.25 Mn | -274,000.00 | 73,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73,000.00 |
| Mar 31, 2026 | 73,000.00 |
| Dec 31, 2025 | 80,000.00 |
| Dec 31, 2025 | 80,000.00 |
| Sep 30, 2025 | 76,000.00 |
| Sep 30, 2025 | 76,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Sep 30, 2024 | 49,000.00 |
| Sep 30, 2024 | 49,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 34,000.00 |
| Mar 31, 2024 | 34,000.00 |
| Dec 31, 2023 | 48,000.00 |
| Dec 31, 2023 | 48,000.00 |